Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 1027-1029

  Halleen, Jussi M ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bone metastases; Breast cancer; Immunoassay; Osteoporosis; Tartrate resistant acid phosphatase 5b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; BIOCHEMICAL MARKER; CELL ANTIGEN; ESTROGEN; MONOCLONAL ANTIBODY; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

BIOACCUMULATION; BONE METASTASIS; BREAST CARCINOMA; CANCER INFILTRATION; CIRCADIAN RHYTHM; CIRCULATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME PURIFICATION; ENZYME RELEASE; IMMUNOASSAY; KIDNEY FAILURE; LIVER FAILURE; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TECHNIQUE;

ACID PHOSPHATASE; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOASSAY; ISOENZYMES; OSTEOBLASTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038199622     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Yaziji H, Janckila AJ, Lear SC, Martin AW and Yam LT: Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 104: 397-402, 1995.
2. Hayman AR, Macary P, Lehner PJ and Cox TM: Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem 49: 675-684, 2001.
3. Minkin C: Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290, 1982.
4. Lam KW, Eastlund DT, Li C-Y and Yam LT: Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 24: 1105-1108, 1978.
5. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ and Vaananen HK: Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 15: 1337-1345, 2000.
6. Takahashi K, Janckila AJ, Sun SZ, Lederer ED, Ray PC and Yam LT: Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis. Clin Chim Acta 301: 147-158, 2000.
7. Lam KW, Li CY, Yam LT and Desnick RJ: Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis. Clin Biochem 14: 177-181, 1981.
8. Janckila AJ, Takahashi K, Sun SZ and Yam LT: Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47: 74-80, 2001.
9. Lau KHW, Onishi T, Wergedal JE, Singer FR and Baylink DJ: Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption. Clin Chem 33: 458-462, 1987.
10. Scarnecchia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R and Mazzuoli GF: Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 51: 517-524, 1991.
11. Rico H and Villa LF: Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling. Calcif Tissue Int 52: 149-150, 1993.
12. Whittaker KB, Cox TM and Moss DW: An immunoassay of human band 5 ("tartrate-resistant") acid phosphatase that involves the use of anti-porcine uteroferrin antibodies. Clin Chem 35: 86-89, 1989.
13. Kraenzlin ME, Lau KHW, Liang L, Freeman TK, Singer FR, Stepan J and Baylink DJ: Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J Clin Endoc Metab 71: 442-451, 1990.
14. Cheung CK, Panesar NS, Haines C, Masarei J and Swaminathan R: Immunoassay of a tartrate-resistant acid phosphatase in serum. Clin Chem 41: 679-686, 1995.
15. Chamberlain P, Compston J, Cox TM, Hayman AR, Imrie RC, Reynolds K and Holmes SD: Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: Development of a specific immunoassay of the isoenzyme in serum. Clin Chem 41: 1495-1499, 1995.
16. Halleen J, Hentunen TA, Hellman J and Vaananen HK: Human bone tartrate-resistant acid phosphatase: Purification and development of an immunoassay. J Bone Miner Res 11: 1444-1452, 1996.
17. Halleen JM, Hentunen TA, Karp M, Kakonen S-M, Pettersson K and Vaananen HK: Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 13: 683-687, 1998.
18. Buhi WC, Ducsay CA, Bazer FW and Roberts RM: Iron transfer between purple phosphatase uteroferrin and transferrin and its possible role in iron metabolism in the fetal pig. J Biol Chem 257: 1712-1723, 1982.
19. Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R and Seibel MJ: Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices. J Bone Miner Res 14: 792-801, 1999.
20. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ and Vaananen HK: Serum tartrate-resistant acid phosphatase is a specific and sensitive marker of bone resorption. Clin Chem 47: 597-600, 2001.
21. Eagleton AC, Eastell R and Blumsohn A: Replicated diurnal profiles of bone turnover markers: sampling time affects within-subject reproducibility. J Bone Miner Res, 16 suppl 1: S345, 2001.
22. Halleen JM, Alatalo SL, Ivaska KK, Cheng S, Uusi-Rasi K, Nenonen A, Kannus P, Sievanen H and Vaananen HK: Serum tartrate-resistant acid phosphatase 5b is a useful marker for monitoring alendronate therapy. J Bone Miner Res 16 (suppl. 1): S534, 2001.
23. Karsdal MA, Garnero P, Ferreras M, Risteli J, Qvist P, Foged T and Delaisse JM: The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 16 (suppl 1): S195, 2001.
24. Clemens JD, Herrick MV, Singer FR and Eyre DR: Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43: 2058-2063, 1997.
25. Bonde M, Garnero P, Fledelius C, Quist P, Delmas PD and Christiansen C: Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12: 1028-1034, 1997.
26. Risteli J, Elomaa I, Niemi S, Novamo A and Risteli L: Radio-immunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39: 635-640, 1993.
27. Guise TA: Molecular mechanisms of osteolytic bone metastases. Cancer 88 (suppl 12): 2892-2898, 2000.
28. Wada N, Ishii S, Ikeda T, Enomoto K and Kitajima M: Serum tartrate-resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res 19: 4515-4521, 1999.